a potential buyer has indicated to us that they would be willing to put an offer on the table after seeing phase 2 results, so for the minimal extra time and cost involved we considered it not a bad bet.
Interesting theory JM. Could this same theory be applied to OxyC after multidose?
It makes sense cost wise and time and resourse wise. But at the risk of being caught out with time and cost if doesnt pan out that way then having to do phase 3 seperate.
More than one way to fry a deal I guess.
oxymorphone patch m eets phase 1 end points, page-27
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.366K | 455.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 60 | 99145902 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 22467224 | 7 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |